Back to all papers

Survival prediction and risk stratification in R0-resected ovarian cancer: a multi-modal deep learning approach.

January 10, 2026pubmed logopapers

Authors

Zhou Y,Duan Y,Teng M,Li S,Zhang H,He F,Gao C,Xiong Y,Wang J,Fan X,Zhang C

Affiliations (7)

  • Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Shanghai Key Laboratory of Data Science, School of Computer Science, Fudan University, Shanghai, China.
  • Department of Ultrasound, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Gaoxin District, Hefei, Anhui, China.
  • Department of Ultrasound, Second People's Hospital of Wuhu, Wuhu, Anhui, China.
  • Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Gaoxin District, Hefei, Anhui, China.
  • Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. [email protected].

Abstract

Ovarian cancer (OC) is a leading cause of gynecologic cancer mortality, with survival prediction limited by existing prognostic models that fail to capture tumor heterogeneity. Conventional methods lack precision for individualized risk assessment. Deep learning (DL) addresses these issues by integrating diverse data to improve survival prediction and risk stratification. This study introduces OvcaSurvivor, a novel multimodal DL framework for R0-resected OC patients, integrating whole-slide images (WSI), ultrasound (US), and clinical data from 543 patients. It uses advanced neural networks (CHIEF for WSI, ResNet50 for US) and an attention-guided fusion module. OvcaSurvivor showed superior performance, with C-indices of 0.81 (internal), 0.76 (external 1), and 0.70 (external 2). Time-dependent AUCs for 1-, 3-, and 5-year survival were highly accurate. WSI features drove prediction, and the model stratified patients into high/low-risk groups, highlighting clinical utility. This multimodal fusion advances OC precision oncology, enabling robust postoperative management.

Topics

Journal Article

Ready to Sharpen Your Edge?

Subscribe to join 8,200+ peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.